Amiprox GmbH

Amiprox was founded in 2022 with the clear vision to streamline, standardize and automate laboratory workflows using centrifugal spin devices. Amiprox patent-protected technology is designed to reduce manual handling and to decrease sample preparation variance. The primary market is proteomics sample preparation due to the demand for standardization while Amiprox technology is applicable to a wide range of laboratory workflow in genomics, lipidomics, metabolomics and specialty analytical fields.